Blood test may reveal hidden cancer remission during immunotherapy

NCT ID NCT06098560

Recruiting now Knowledge-focused Sponsor: Geneplus-Beijing Co. Ltd. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 27 times

Summary

This study looks at 60 people with a specific type of advanced colorectal cancer (dMMR/MSI-H) who are receiving immunotherapy. Researchers want to see if changes in a blood test called ctDNA can tell if the cancer is truly gone, even when scans don't show it. The goal is to find a better way to monitor treatment success without relying only on imaging.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Fudan University Shanghai Cancer Center
RECRUITING

Shanghai, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Peking Union Medical College Hospital
RECRUITING

Beijing, Beijing Municipality, 100730, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

COLORECTAL CANCER